Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

AGM Statement

18 Jul 2018 07:00

RNS Number : 9392U
Renold PLC
18 July 2018
 

Renold plc

 

("Renold", "the Company" or "the Group")

 

AGM Statement

 

18 July 2018

 

Renold, a leading international supplier of industrial chains and related power transmission products, is today issuing, ahead of its Annual General Meeting to be held at 11:00am today, the following statement in respect of the first quarter of the financial year ending 31 March 2019 ('the Quarter').

 

The Quarter saw overall Group performance in line with expectations. Improving order intake in the second half of the previous year was converted into growth in underlying1 revenue in the Quarter of 3.7%, compared to the first quarter of the prior year. Higher sales are being delivered in both divisions, with underlying revenue ahead by 3.1% for Chain and 4.9% for Torque Transmission.

 

The trend of orders growing at a faster rate than revenue has continued into the early part of the new financial year, with order intake in the Quarter 9.2% ahead of revenue in the same period (book to bill ratio). Underlying order intake was 12% higher than in the first quarter of the prior year (excluding the major multi-year project win by UK Couplings in June 2017).

 

Progress continues to be made in building our new Chinese chain factory, with construction nearing completion. The phased transfer of manufacturing operations will be undertaken over the coming months, with full operation from the new facility scheduled for the end of the financial year.

 

The Group remains on track to deliver a result for the full year in line with the Board's expectations.

 

Robert Purcell, Chief Executive of Renold, said:

"Strong order intake in the latter part of the prior year supported growing revenues in the Quarter across most of our geographic regions, with the Americas particularly strong in both the Chain and Torque Transmission divisions.

 

"Continued revenue growth provides the platform for margin improvement supported by continued progress in delivering against our strategic plan."

 

(1) The use of "underlying" excludes the impact of changes in foreign exchange rates by re-translating the prior year comparative figures to the current year exchange rate.

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

 

Ian Scapens, Group Finance Director

 

 

 

Arden Partners

020 7614 5917

Chris Hardie

 

Ben Cryer

 

 

 

Instinctif Partners

020 7457 2020

Mark Garraway

 

Helen Tarbet

Rosie Driscoll

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSFWFIWFASEDW
Date   Source Headline
23rd Nov 20161:48 pmRNSHolding(s) in Company
15th Nov 20167:00 amRNSHalf-year Report
13th Oct 201612:02 pmRNSPrice Monitoring Extension
13th Oct 20167:00 amRNSTrading Update
11th Oct 201612:07 pmRNSSecond Price Monitoring Extn
11th Oct 201612:02 pmRNSPrice Monitoring Extension
4th Oct 20162:28 pmRNSHolding(s) in Company
28th Sep 20167:45 amRNSHolding(s) in Company
16th Sep 20164:35 pmRNSPrice Monitoring Extension
6th Sep 20167:00 amRNSAppointment of new Finance Director
1st Sep 20167:00 amRNSUpdate on Strategic Plan
1st Aug 201611:31 amRNSBlock listing Interim Review
22nd Jul 20162:59 pmRNSEmployee Benefit Trust
21st Jul 20163:07 pmRNSGrant of Awards - Performance Share Plan
20th Jul 201611:33 amRNSResult of AGM
20th Jul 20167:01 amRNSDirectorate Change
20th Jul 20167:00 amRNSAGM Statement
17th Jun 20167:00 amRNSNotice of AGM
31st May 20167:00 amRNSRenold FY Results YE 31 March 2016
14th Apr 20169:00 amRNSNotice of Results
14th Apr 20167:00 amRNSTrading Update
12th Apr 20169:38 amRNSHolding(s) in Company
16th Feb 20169:08 amRNSHolding(s) in Company
12th Feb 201610:44 amRNSDirector/PDMR Shareholding
12th Feb 201610:21 amRNSHolding(s) in Company
12th Feb 201610:21 amRNSHolding(s) in Company
12th Feb 20169:42 amRNSHolding(s) in Company
11th Feb 201612:53 pmRNSDirector/PDMR Shareholding
11th Feb 20169:28 amRNSDirector/PDMR Shareholding
10th Feb 20167:00 amRNSTrading Update
2nd Feb 20168:04 amRNSBlocklisting Interim Review
5th Jan 20167:00 amRNSCompletion of the acquisition of Aventics TC
4th Jan 20162:27 pmRNSHolding(s) in Company
7th Dec 20157:00 amRNSRe Pensions
2nd Dec 201510:02 amRNSHolding(s) in Company
17th Nov 201512:20 pmRNSHolding(s) in Company
17th Nov 20157:01 amRNSAcquisition
17th Nov 20157:00 amRNSHalf Yearly Report
6th Oct 20159:54 amRNSHolding(s) in Company
19th Aug 201512:48 pmRNSHolding(s) in Company
3rd Aug 20157:00 amRNSBlocklisting Interim Review
21st Jul 20154:11 pmRNSResult of AGM
21st Jul 20157:00 amRNSAGM Statement
19th Jun 20157:00 amRNSAnnual Report and Accounts
17th Jun 20154:58 pmRNSHolding(s) in Company
11th Jun 20155:36 pmRNSTR-1: Notification of Major Interest in Shares
9th Jun 20159:07 amRNSGrant of Awards - Performance Share Plan
26th May 20157:01 amRNSFinal Results
14th May 20157:00 amRNSStrategic Banking Partnership
29th Apr 20157:01 amRNSDe-risking exercise for the Renold Pension Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.